hexamethylene bisacetamide has been researched along with triazoles in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bartholomeeusen, K; Fujinaga, K; Peterlin, BM; Xiang, Y | 1 |
| Cheng, WJ; Churchill, MJ; Ellett, AM; Gorry, PR; Gray, LR; Jacobson, JC; Lewin, SR; Lu, HK; Moso, MA; On, H; Papaioannou, C; Purcell, DF; Raison, JA; Roberts, E; Wesselingh, SL | 1 |
| Funck-Brentano, E; Nilsson, JA; Nilsson, LM; Vizlin-Hodzic, D | 1 |
3 other study(ies) available for hexamethylene bisacetamide and triazoles
| Article | Year |
|---|---|
Bromodomain and extra-terminal (BET) bromodomain inhibition activate transcription via transient release of positive transcription elongation factor b (P-TEFb) from 7SK small nuclear ribonucleoprotein.
Topics: Acetamides; Azepines; Cell Cycle Proteins; Cell Line; Gene Knockdown Techniques; HIV-1; Humans; Nuclear Proteins; Positive Transcriptional Elongation Factor B; Ribonucleoproteins, Small Nuclear; RNA Polymerase II; RNA-Binding Proteins; Transcription Elongation, Genetic; Transcription Factors; Transcriptional Elongation Factors; Triazoles; Ultraviolet Rays; Viral Proteins | 2012 |
Toxicity and in vitro activity of HIV-1 latency-reversing agents in primary CNS cells.
Topics: Acetamides; Astrocytes; Azepines; Cell Line; Cell Survival; Depsipeptides; Disulfiram; Fetus; Histone Deacetylase Inhibitors; HIV-1; Humans; Hydroxamic Acids; Indoles; Macrophages; Neurons; Panobinostat; Piperazines; Primary Cell Culture; Transcription, Genetic; Triazoles; Virus Activation; Virus Latency; Virus Replication; Vorinostat | 2016 |
BET bromodomain inhibitor HMBA synergizes with MEK inhibition in treatment of malignant glioma.
Topics: Acetamides; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Azepines; Brain Neoplasms; Cell Line, Tumor; Drug Synergism; Glioma; Humans; Mice; Mitogen-Activated Protein Kinase Kinases; Protein Kinase Inhibitors; Rats; Transcription Factors; Triazoles | 2021 |